Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» type 2 diabetes
type 2 diabetes
Sanofi ends partnership with Lexicon to develop add-on pill for diabetes
Yahoo/Reuters
Sat, 07/27/19 - 01:58 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
type 2 diabetes
diabetes
insulin
Lilly's Study on Higher Doses of Trulicity Meets Endpoint
Yahoo/Zacks.com
Thu, 06/27/19 - 06:43 pm
Eli Lilly
clinical trials
type 2 diabetes
Trulicity
Novo Nordisk’s Victoza gets FDA okay for pediatric use
Pharmaforum
Tue, 06/18/19 - 10:10 am
Novo Nordisk
Victoza
type 2 diabetes
pediatric
Lilly plans phase 2b NASH trial of dual GIP, GLP-1 agonist
Fierce Biotech
Mon, 06/10/19 - 09:39 am
Eli Lilly
NASH
tirzepatide
clinial trials
ADA
type 2 diabetes
Beyond glucose in type 2 diabetes: how Novo Nordisk is looking to address chronic kidney disease
Pharmaforum
Wed, 06/5/19 - 12:01 am
Novo Nordisk
type 2 diabetes
diabetes
chronic kidney disease
Insulin Patch Earns Spot in American Diabetes Association Guidelines for Diabetes Care
Xtalks
Thu, 05/30/19 - 05:31 pm
diabetes
type 2 diabetes
insulin patch
ADA
Valeritas
V-Go
devices
Oramed spearheading human oral insulin trials in 37 US centers
CP Wire
Thu, 05/9/19 - 01:06 pm
Oramed
insulin
oral insulin
diabetes
type 2 diabetes
clinical trials
Oramed spearheading human oral insulin trials in 37 US centers
Fri, 05/10/19 - 10:40 am
Oramed
insulin
type 2 diabetes
diabetes
clinical trials
oral insulin
FDA approves AstraZeneca's triple combination therapy for type 2 diabetes
Healio
Fri, 05/3/19 - 11:19 am
AstraZeneca
type 2 diabetes
FDA
Qternmet XR
Novo seeks Victoza label expansion with fresh pediatric trial results
Biopharma Dive
Mon, 04/29/19 - 09:33 pm
Novo Nordisk
type 2 diabetes
pediatrics
Victoza
BI and Lilly's diabetes drug Jardiance reverses heart failure in animal models
Fierce Biotech
Fri, 04/19/19 - 10:34 am
Eli Lilly
Boehringer Ingelheim
Jardiance
type 2 diabetes
heart failure
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Pharmaforum
Wed, 04/10/19 - 11:40 pm
Poxel
Japan
diabetes
type 2 diabetes
clinical trials
imeglimin
Intarcia licenses Numab's autoimmune therapy
BioCentury
Wed, 03/6/19 - 10:04 am
Intarcia
Numab
BD016
type 2 diabetes
AstraZeneca gets FDA expanded approval for Farxiga and Xigduo XR
Pharmaceutical Business Review
Thu, 02/28/19 - 11:45 pm
AstraZeneca
type 2 diabetes
Farxiga
Xigduo XR
FDA
Boehringer Ingelheim and Lilly announce the CAROLINA cardiovascular outcome trial of Tradjenta met its primary endpoint of non-inferiority compared with glimepiride
Pharmaceutical Business Review
Fri, 02/15/19 - 10:13 am
Boehringer Ingelheim
Eli Lilly
glimepiride
linagliptin
Tradjenta
type 2 diabetes
clinical trials
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Fierce Biotech
Thu, 01/3/19 - 09:45 am
Merck
NASH
NGM Biopharmaceuticals
type 2 diabetes
clinical trials
MK-3655
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
BioSpace
Mon, 11/26/18 - 12:30 pm
Zafgen
clinical trials
FDA
diabetes
ZGN-1061
type 2 diabetes
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Mon, 11/26/18 - 09:56 am
Novo Nordisk
semaglutides
type 2 diabetes
clinical trials
cardiovascular outcomes
Millions left behind as diabetes drives surge in insulin demand
Reuters
Wed, 11/21/18 - 09:52 am
diabetes
type 2 diabetes
insulin
A startup for diabetes patients rolls out a new model: Insurers only pay if the service works
Stat
Wed, 11/14/18 - 10:32 am
devices
digital coaching
type 2 diabetes
Virta Health
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »